Skip to main content

Full text of "USPTO Patents Application 09804625"

See other formats


PATENT 
Customer No, 22,852 
Attorney Docket No. 08702.0039-02000 



AMENDMENTS TO THE CLAIMS: 

This listing of claims replaces all prior versions and listings of claims in this 
application: 

1-23. (Cancelled) 

24. (Currently amended) An isolated polynucleotide comprising: 

a) nucleotide 1252 through 1543 of Figwe-2 -SEQ ID NO:3 : or 

b) nucleotides encoding amino acids 299 through 396 of Figur e 2 SEQ ID 

NO:4 . 

25. (Cancelled) 

26. (Currently amended) An isolated polynucleotide comprising nucleotides 
1252 through 1543 offiawe-2- SEQ ID NO:3 . 

27-29. (Cancelled) 

30. (Currently amended) An isolated polynucleotide comprising nucleotides 
encoding amino acids 299 through 396 of F i gure 2 SEQ ID NO:4 . 
31-34. (Cancelled) 

35. (Previously presented) A vector comprising a polynucleotide of claim 24 
in operative association with an expression control sequence therefor. 
36-37. (Cancelled) 

38. (Previously presented) A host cell transformed with a vector of claim 35. 
39-41. (Cancelled) 



-2- 



PATENT 
Customer No. 22,852 
Attorney Docket No. 08702.0039-02000 



42. (Previously presented) A method for producing a bone morphogenetic 
protein, said method comprising the steps of: 

a) culturing a host cell transformed with a polynucleotide of claim 24, and 

b) recovering said bone morphogenetic protein. 
43-54. (Cancelled) 



-3-